Sun Pharmaceutical Industries has reported results for first quarter ended June 30, 2021.
The company has reported 21.18% fall in its net profit at Rs 419.30 crore for the quarter under review as compared to net profit of Rs 531.95 crore for the same quarter in the previous year. However, total income of the company increased by 13.39% at Rs 3383.75 crore for Q1FY22 as compared Rs 2984.23 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported net profit after taxes, share of profit of associates and joint ventures and non-controlling interests at Rs 1444.17 crore for the quarter under review as compared to net loss of Rs 1655.60 crore for the same quarter in the previous year. Total income of the company increased by 22.55% at Rs 9871.26 crore for Q1FY22 as compared Rs 7739.04 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1786.05 |
Dr. Reddys Lab | 1354.20 |
Cipla | 1470.05 |
Lupin | 2190.50 |
Zydus Lifesciences | 1004.05 |
View more.. |